UnratedDrug recall · FDA · Published February 15, 2024
Eugia recalls Methocarbamol injection with particulate matter risk
Eugia US LLC recalls 10mL Methocarbamol injection vials due to particulate matter. This may cause serious injury if injected. Affected units were manufactured in India with specific lot number.
“Eugia recalls Methocarbamol injection with particulate matter risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32817-eugia-recalls-methocarbamol-injection-with-particulate-matter-risk. Based on FDA recall #D-0440-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0440-2024%22&limit=1).
The FDA announced on Feb. 15, 2024, that Eugia US LLC is recalling Methocarbamol Injection due to the presence of particulate matter. Owners should stop use and contact the company for a refund.
How to tell if you have it
Brand: Eugia
Product: Methocarbamol Injection, USP 1000mg/10mL (100mg/mL), 10 mL Single-Dose Vial
NDC: 55150-223-10
Lot #: 3MC23011
Expiration Date: 11/30/2026
Distribution: Nationwide in the USA
The hazard
The recall is due to the presence of particulate matter in the injection vials. The FDA classified this as a Class I recall, indicating a high risk of adverse health consequences.
Context
GovInfoNow's records show Eugia US LLC has issued 14 other recalls since Dec. 28, 2022. Recent Eugia recalls include Lidocaine injection on May 18, 2026, and Gentamicin Injection on May 29, 2025. Other recent recalls of similar products include GE Healthcare Omnipaque 300 mg/mL Injection (March 24, 2026), American Regent Papaverine HCl Injection (July 24, 2026), and Apollo Care SEMAGLUTIDE Vial (July 29, 2026).
How to tell if you have this one
Check for vials labeled 'Methocarbamol Injection, USP 1000mg/10mL (100mg/mL), 10 mL Single-Dose Vial' packed 25 per carton. The lot number 3MC23011 was manufactured in India with expiration date 11/30/2026.
Brand
Eugia
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Vial Details
Look for the lot number 3MC23011 on the vial packaging to confirm if it is affected.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 2 months after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0440-2024 (February 15, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0440-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.